IHS Chemical Week

Regions :: Western Europe :: Switzerland

Lonza and Organobalance Sign License Agreement

12:31 AM MDT | April 19, 2011 | Deepti Ramesh

Lonza says it has signed a worldwide exclusive license agreement with Organobalance (Berlin, Germany), in which Lonza will develop, produce and commercialize products containing a probiotic Lactobacillus strain. Developed by Organobalance, the probiotic strain acts against Helicobacter pylori (H. pylori), which has been implicated as a common cause of peptic ulcers and gastritis. In close cooperation with industry partners, Organobalance develops biological products in the fields of pharmaceutics, preventive health care, nutrition and cosmetics. Organobalance...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa